PMCA1 Deletion Leads to Increased Blood Pressure and Cardiac Hypertrophy

Faculty Pharmacy Year: 2014
Type of Publication: ZU Hosted Pages:
Authors:
Sally Kamel Abdelattef
Journal: Heart BMJ Publishing Group Ltd and British Cardiovascular Society Volume:
Keywords : PMCA1 Deletion Leads , Increased Blood Pressure    
Abstract:
Introduction Heart failure is the common and final end point of cardiovascular disease. Seventy four percent of congestive heart failure patients also suffer from hypertension. Genome wide association studies (GWAS) have recently identified
    
     
 
       

Author Related Publications

  • Sally Kamel Abdelattef, "Obesity and neurodegeneration: effect of a Mediterranean dietary pattern", Taylor & Francis Group, 2010 More
  • Sally Kamel Abdelattef, "Biochemical effect of a ketogenic diet on the brains of obese adult rats", ScienceDirect, 2010 More
  • Sally Kamel Abdelattef, "Long Noncoding RNA Function and Expression in Cancer", Springer-Verlag Berlin Heidelberg, 2011 More
  • Sally Kamel Abdelattef, "Ablation of the Hypertension Candidate Gene ATP2B1 Results in Increased Blood Pressure and Cardiac Hypertrophic Remodeling", Lippincott Williams & Wilkins, 2014 More
  • Sally Kamel Abdelattef, "Global PMCA1 deletion leads to increased blood pressure and left ventricular hypertrophy", WILEY-BLACKWELL, 2014 More

Department Related Publications

  • Nahla Nabil Mohamed Youns, "10-Dehydrogingerdione raises HDL-cholesterol through a CETP inhibition and wards off oxidation and inflammation in dyslipidemic rabbits", 2013 Elsevier Ireland Ltd, 2013 More
  • Mohamed Mahmoud Swedy, "10-Dehydrogingerdione raises HDL-cholesterol through a CETP inhibition and wards off oxidation and inflammation in dyslipidemic rabbits", 2013 Elsevier Ireland Ltd, 2013 More
  • Fatma Rezk Abdallah Ibrahiem, "10-Dehydrogingerdione raises HDL-cholesterol through a CETP inhibition and wards off oxidation and inflammation in dyslipidemic rabbits", 2013 Elsevier Ireland Ltd, 2013 More
  • Sally Kamel Abdelattef, "Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: Role of SIRT1/FOXO3a and Wnt/β-catenin pathways", ELsevier, 2021 More
Tweet